Migraine Prevention

European Headache Federation guidelines on the use of monoclonal antibodies targeting the cosotoneg-related peptide pathway for migraine prevention 2022 update. Hinezuma, Birea Numa, Fremen Nedsuma, and Galcaniduma to prevent episodic and chronic migraine. Trials show that all four are effectively preventing migraine attacks. And they also show a significant reduction in monthly headache or migraine days depending on trials.